Activist investor William Ackman and Valeant Pharmaceuticals revealed their offer to acquire Allergan, valuing the wrinkle treatment maker at about $46 billion, the Wall Street Journal reports.
11150 Santa Monica Boulevard, Suite 350
Los Angeles, CA 90025
323-549-5225
© Los Angeles Business Journal